Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

ישראלמגייס משתתפיםPHASE3

מצבים רפואיים

Early Breast Cancer

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

Central Alabama Research, Birmingham, Alabama, United States
Contact: Study coordinator (Lorie Szymela) · LSzymela@centralalabamaresearch.com
Contact: Principal Investigator (David Mooney)
Alaska Oncology and Hematology LLC, Anchorage, Alaska, United States
Contact: Study coordinator (Talia Wyckoff) · talia@alaskaoncology.com · 907-279-3155
Contact: Principal Investigator (Steven Liu)
Western Reg MC-COH Phoenix, Goodyear, Arizona, United States
Contact: Study coordinator (Susan Sheerin-Fadden) · ssheerinfadden@coh.org · 623-207-3381
Contact: Principal Investigator (Cynthia Lynch)
CARTI Cancer Center, Little Rock, Arkansas, United States
Contact: Study coordinator (Emily Johnson) · Emily.Johnson@carti.com · 501-906-3000
Contact: Principal Investigator (Issam Sam Makhoul)
Beverly Hills Cancer Center, Beverly Hills, California, United States
Contact: Study coordinator (Carlos Jovel) · CJovel@bhcancercenter.com · 310-432-8900
Contact: Principal Investigator (Linnea Chap)
Onco Inst of Hope and Innovation, Cerritos, California, United States
Contact: Study coordinator (Sabrina Mora) · sabrina.mora@heliosclinical.com · 562-698-6888
Contact: Principal Investigator (Pamela Miel)
City of Hope National Medical, Duarte, California, United States
Contact: Study coordinator (Felicia Lewis) · flewis@coh.org · +1 6263598111#65994
Contact: Principal Investigator (Thanh Nga Doan)
Providence Medical Foundation, Fullerton, California, United States
Contact: Study coordinator (Teresa Olea) · teresa.olea@stjoe.org · 714-449-6200
Contact: Principal Investigator (Giribala R Patel)
Palo Alto Medical Foundation, Mountain View, California, United States
Contact: Study coordinator (Christine Lee) · christine.lee4@sutterhealth.org · 650-853-5763
Contact: Principal Investigator (Natalia Colocci)
UC Irvine Medical Center, Orange, California, United States
Contact: Study coordinator (Stephany Ruiz) · ruizs11@hs.uci.edu · 714-456-6288
Contact: Principal Investigator (Ritesh Parajuli)
Sutter Inst Medical Research, Sacramento, California, United States
Contact: Study coordinator (Clara Dunn) · dunncm@sutterhealth.org · 916-453-5742
Contact: Principal Investigator (Nitin Rohatgi)
School Of Medicine, Sacramento, California, United States
Contact: Study coordinator (Apinya Vorasaph) · avorasaph@health.ucdavis.edu
Contact: Principal Investigator (Mili Arora)
Rocky Mountain Cancer Centers, Denver, Colorado, United States
Contact: Study coordinator (Kathryn Wilson) · kathryn.wilson@usoncology.com · 303-321-0302
Contact: Principal Investigator (Mabel Mardones)
Georgetown University Lombardi Cancer Center, Washington D.C., District of Columbia, United States
Contact: Study coordinator (Julie Castle) · bickmorj@georgetown.edu · 202-687-8676
Contact: Principal Investigator (Katia Khoury)
Washington Hospital Center, Washington D.C., District of Columbia, United States
Contact: Study coordinator (Stacy Malloy) · Stacy.K.Malloy@medstar.net · 202-877-2146
Contact: Principal Investigator (Ami Chitalia)
AdventHealth Altamonte Springs, Altamonte Springs, Florida, United States
Contact: Study coordinator (Rebecca Iorio) · rebecca.iorio@adventhealth.com
Contact: Principal Investigator (Wassim Mchayleh)
Holy Cross Health, Fort Lauderdale, Florida, United States
Contact: Study coordinator (Eileen Georgi) · Eileen.Georgi@holy-cross.com · 954-771-8000
Contact: Principal Investigator (Karim Arnaout)
Hialeah Hospital, Hialeah, Florida, United States
Contact: Study coordinator (Jonathan Matias) · jmatias@bioresearchpartner.com
Contact: Principal Investigator (Luis G Rangel)
Memorial Cancer Institute, Hollywood, Florida, United States
Contact: Study coordinator (Florencia Brunengo) · fbrunengo@mhs.net
Contact: Principal Investigator (Adriana Milillo Naraine)
Jupiter Medical Center, Jupiter, Florida, United States
Contact: Study coordinator (Christine Leonard) · christine.leonard@jupitermed.com · 561-263-5768
Contact: Principal Investigator (Danielle Krol)
Ocala Research Institute, Inc, Ocala, Florida, United States
Contact: Study coordinator (Michelle Jackson) · Michelle.Jackson@usoncology.com · 352-351-7126
Contact: Principal Investigator (Anju Vasudevan)
University Cancer and Blood Center LLC, Athens, Georgia, United States
Contact: Study coordinator (Christen Nicole Cooper Pope) · npope@universitycancer.com
Contact: Principal Investigator (Amanda Hathaway)
Summit Cancer Care PC, Savannah, Georgia, United States
Contact: Study coordinator (Theresa Williams) · twilliams@summitcancercare.com
Contact: Principal Investigator (Mark A Taylor)
Hawaii Cancer Care, Honolulu, Hawaii, United States
Contact: Study coordinator (Angelei Gommesen) · AngeleiJan.Gommesen@aoncology.com
Contact: Principal Investigator (Arnold K N Yee)
Affiliated Oncologists IL, Chicago, Illinois, United States
Contact: Study coordinator (Angela Malone) · angela.malone@usoncology.com
Contact: Principal Investigator (Rami Haddad)
Hope And Healing Care, Hinsdale, Illinois, United States
Contact: Study coordinator (Divya Mudavath) · dmudavath@hopenheal.care
Contact: Principal Investigator (Srilata Gundala)
Midwestern Reg MC COH Chicago, Zion, Illinois, United States
Contact: Study coordinator (Afua Amoabin) · aamoabin@coh.org · 847-872-4561
Contact: Principal Investigator (Ajaz Khan)
Investigative Clinical R of Indiana, Indianapolis, Indiana, United States
Contact: Study coordinator (Zara Edgell) · zedgell@investigativeicr.com
Contact: Principal Investigator (Ruemu Birhiray)
University of Iowa Health Care, Waukee, Iowa, United States
Contact: Study coordinator (Theresa Caon) · tcaon@missioncancer.com
Contact: Principal Investigator (Seema Harichand-Herdt)
University of Kansas Cancer Center, Westwood, Kansas, United States
Contact: Study coordinator (Chasity Cupp) · ccupp@kumc.edu
Contact: Principal Investigator (Priyanka Sharma)
Cancer Center of Kansas, Wichita, Kansas, United States
Contact: Study coordinator (Michelle Comstock) · michelle.comstock@cancercenterofkansas.com · 316-262-4467
Contact: Principal Investigator (Shaker R Dakhil)
Willis-Knighton Cancer Center, Shreveport, Louisiana, United States
Contact: Study coordinator (Briana Barrow) · bbarrow@wkhs.com
Contact: Principal Investigator (Prakash Peddi)
Mercy Medical Center, Baltimore, Maryland, United States
Contact: Study coordinator (Alexandra Cline) · acline@mdmercy.com · +1 410 332 1200
Contact: Principal Investigator (David Andrew Riseberg)
Maryland Oncology Hematology P A, Silver Spring, Maryland, United States
Contact: Study coordinator (Teresa Saavedra) · teresa.saavedra@usoncology.com
Contact: Principal Investigator (Carol Tweed)
Boston Medical Center, Boston, Massachusetts, United States
Contact: Study coordinator (Tara Hassani Goodarzi) · tara.hassanigoodarzi@bmc.org
Contact: Principal Investigator (Jose J Acevedo)
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Study coordinator (Celine Ibrahim) · celine_ibrahim@dfci.harvard.edu · 617-632-5607
Contact: Principal Investigator (Erica Mayer)
Dana Farber Brigham Women Cancer, Milford, Massachusetts, United States
Contact: Study coordinator (Laura Melancon) · laurae_melancon@dfci.harvard.edu · 617-732-9850
Contact: Principal Investigator (Natalie Sinclair)
Minnesota Oncology Hematology P A, Minneapolis, Minnesota, United States
Contact: Study coordinator (Anne Rabenn) · Anne.rabenn@usoncology.com
Contact: Principal Investigator (Eric Lander)
Allina Hlth Cancer Inst Minneapolis, Minneapolis, Minnesota, United States
Contact: Study coordinator (Jonathan Alexander) · jonathan.alexander@allina.com · 612-863-9466
Contact: Principal Investigator (Daniel Carlson)
Jackson Oncology Associates, Jackson, Mississippi, United States
Contact: Study coordinator (Teresa Davis) · tdavis@jacksononcology.com · 601-974-5547
Contact: Principal Investigator (Justin T Baker)
HCA Midwest Division, Kansas City, Missouri, United States
Contact: Study coordinator (Katie Burnside) · katherine.burnside@hcahealthcare.com
Contact: Principal Investigator (Anis Toumeh)
WA Uni School Of Med, St Louis, Missouri, United States
Contact: Study coordinator (Elizabeth Ainsworth) · ainsworth@wustl.edu · 314-747-8085
Contact: Principal Investigator (Katherine Clifton)
Intermountain Healthcare, Billings, Montana, United States
Contact: Study coordinator (Kelsi Margaris) · kelsi.margaris@imail.org
Contact: Principal Investigator (Patrick Cobb)
Nebraska Cancer Specialists, Omaha, Nebraska, United States
Contact: Study coordinator (Heather Cordes) · hcordes@nebraskacancer.com · +1 402 334 4773
Contact: Principal Investigator (Margaret Barbara Block)
Renown Regional Medical Center, Reno, Nevada, United States
Contact: Study coordinator (Bayley Stoner) · Bayley.Stoner@renown.org
Contact: Principal Investigator (Lee Schwartzberg)
Cancer Care Specialists, Reno, Nevada, United States
Contact: Study coordinator (Layla Quinonez) · Lquinonez@ccsreno.com
Contact: Principal Investigator (Sowjanya Reganti)
Summit Health, Florham Park, New Jersey, United States
Contact: Study coordinator (Mehmet Kurt) · mkurt4@summithealth.com · 973-538-5210
Contact: Principal Investigator (Steven Papish)
The Valley Hospital, Ridgewood, New Jersey, United States
Contact: Study coordinator (Emily Clark) · eclark2@valleyhealth.com
Contact: Principal Investigator (Amanda Podolski)
Presbyterian Medical Group, Albuquerque, New Mexico, United States
Contact: Study coordinator (Monique Robertson) · mrobertso2@phs.org · 505-559-6100
Contact: Principal Investigator (Yashvin Onkarappa Mangala)
Queens Cancer Center of Queens Hospital, Jamaica, New York, United States
Contact: Study coordinator (Linda Bulone) · buLoneL@nychhc.org · 718-883-3751
Contact: Principal Investigator (Ellen Hagopian)
Optum Health, Lake Success, New York, United States
Contact: Study coordinator (Rabia Khan) · rabia.khan2@uhn.ca · +1 516 488 2918#183
Contact: Principal Investigator (Jonathan Goldberg)
Mount Sinai School of Medicine, New York, New York, United States
Contact: Study coordinator (Weronika Bucwinska) · weronika.bucwinska@mssm.edu
Contact: Principal Investigator (Melanie Kier)
Duke Cancer Network, Durham, North Carolina, United States
Contact: Study coordinator (Catrin Davies) · catrin.davies@duke.edu
Contact: Principal Investigator (Madhu Chaudhry)
Cone Health Cancer Center, Greensboro, North Carolina, United States
Contact: Study coordinator (Nikki Eldreth) · Nikki.Eldreth@conehealth.com · 336-832-1100
Contact: Principal Investigator (Vinay Gudena)
Sanford Research USD Fargo, Fargo, North Dakota, United States
Contact: Study coordinator (Riley Klueber) · riley.klueber@sanfordhealth.org · 701-234-2371
Contact: Principal Investigator (Anu Goel Gaba)
Good Samaritan Regional Medical Center, Corvallis, Oregon, United States
Contact: Study coordinator (Esther VanTil) · evantil@samhealth.org · 541-768-5800
Contact: Principal Investigator (John Strother)
Oncology Associates of Oregon PC, Eugene, Oregon, United States
Contact: Study coordinator (Spencer Dandy) · Spencer.dandy@usoncology.com
Contact: Principal Investigator (Miho Dougherty)
Northwest Cancer Specialists, Portland, Oregon, United States
Contact: Study coordinator (Heather Firneisz) · Heather.Firneisz@usoncology.com · 971-708-7600
Contact: Principal Investigator (Jay Andersen)
Oregon Oncology Specialists Salem, Salem, Oregon, United States
Contact: Study coordinator (Kyla Kinney) · kkinney@orcancer.com
Contact: Principal Investigator (Janelle Meyer)
Consultants In Med Onco And Hema, Drexel Hill, Pennsylvania, United States
Contact: Study coordinator (Maureen Lisowski) · maureen.Lisowski@usoncology.com
Contact: Principal Investigator (Alexander Deak)
Univ of Pittsburg Med Ctr Pinnacle, Harrisburg, Pennsylvania, United States
Contact: Study coordinator (Bridgett West) · westb@upmc.edu · 717-652-3000
Contact: Principal Investigator (Marija Balic)
Rhode Island Hospital, Providence, Rhode Island, United States
Contact: Study coordinator (Janine Grigelevich) · jgrigelevich@brownhealth.org · 401-444-7525
Contact: Principal Investigator (Stephanie Graff)
Bon Secours St Francis Cancer Center, Greenville, South Carolina, United States
Contact: Study coordinator (Christine Sanchez) · Christine_Sanchez@bshsi.org · +1 864 603 6214
Contact: Principal Investigator (Stephen Howard Dyar)
Lexington Medical Center, West Columbia, South Carolina, United States
Contact: Study coordinator (Katharine Madden) · kdmadden@lexhealth.org · 803-794-7511
Contact: Principal Investigator (Steven Madden)
Regional Medical Oncology NC, Wilson, South Carolina, United States
Contact: Study coordinator (Merdith Best) · meredith.best@regionaloncology.com
Contact: Principal Investigator (Keith Lerro)
Sanford USD Medical Center, Sioux Falls, South Dakota, United States
Contact: Study coordinator (Jane Veerman) · jane.veerman@sanfordhealth.org · 605-328-8000
Contact: Principal Investigator (Allison Watson)
Sarah Cannon Research Institute, Nashville, Tennessee, United States
Contact: Study coordinator (Madeleine Enos) · madeleine.enos@scri.com · 615-329-7270
Contact: Principal Investigator (Denise A Yardley)
El Paso Texas Oncology, El Paso, Texas, United States
Contact: Study coordinator (Mary Williams) · mary.williams2@usoncology.com
Contact: Principal Investigator (Ines Sanchez-Rivera)
Kelsey Seybold Clinic, Houston, Texas, United States
Contact: Study coordinator (Shawndra Alexander) · shawndra.alexander@kelseyresearch.com · 713-442-1224
Contact: Principal Investigator (Sunil Patel)
University of Texas, Houston, Texas, United States
Contact: Study coordinator (Cynthia Tamez) · ctamez@mdanderson.org · 713-794-5783
Contact: Principal Investigator (Jason Mouabbi)
Texas Oncology P A Plano East, Plano, Texas, United States
Contact: Study coordinator (Kristy Dillard) · Kristy.Dillard@usoncology.com · 972-867-3577
Contact: Principal Investigator (Carlos Taboada)
Texas Oncology PA Tyler, Tyler, Texas, United States
Contact: Study coordinator (Jennifer Castner) · jennifer.castner@usoncology.com
Contact: Principal Investigator (Nanna Sulai)
Bon Secours Virginia Health System, Midlothian, Virginia, United States
Contact: Study coordinator (Mary M Williams) · Mary_Williams7@bshsi.org · 804-894-8665
Contact: Principal Investigator (William Irvin)
Virginia Oncology Associates, Norfolk, Virginia, United States
Contact: Study coordinator (Patricia Innis-Deleon) · patricia.deleon@usoncology.com
Contact: Principal Investigator (Michael A Danso)
Kadlec Clinic Hematology and Onco, Kennewick, Washington, United States
Contact: Study coordinator (Heather Harris) · heather.e.harris@kadlec.org · 509-783-0144
Contact: Principal Investigator (Ying Zhuo)
Providence Regional Cancer System, Lacey, Washington, United States
Contact: Study coordinator (Deidre Dillon) · deidre.dillon@providence.org · 360-754-3934
Contact: Principal Investigator (Mijung Lee)
Valley Medical Center Research, Renton, Washington, United States
Contact: Study coordinator (Dione Froman) · Dione_Froman@valleymed.org
Contact: Principal Investigator (Navanshu Arora)
Northwest Medical Specialties, Tacoma, Washington, United States
Contact: Study coordinator (Patricia Walsh) · pwalsh@nwmsonline.com · 253-428-8756
Contact: Principal Investigator (Sibel Blau)
Novartis Investigative Site, Caba, Buenos Aires, Argentina
Novartis Investigative Site, La Plata, Buenos Aires, Argentina
Novartis Investigative Site, Córdoba, Argentina
Novartis Investigative Site, Gateshead, New South Wales, Australia
Novartis Investigative Site, Tiwi, Northern Territory, Australia
Novartis Investigative Site, Clayton, Victoria, Australia
Novartis Investigative Site, East Melbourne, Victoria, Australia
Novartis Investigative Site, Salvador, Estado de Bahia, Brazil
Novartis Investigative Site, Salvador, Estado de Bahia, Brazil
Novartis Investigative Site, Porto Alegre, Rio Grande do Sul, Brazil
Novartis Investigative Site, Porto Alegre, Rio Grande do Sul, Brazil
Novartis Investigative Site, São Paulo, São Paulo, Brazil
Novartis Investigative Site, São Paulo, Brazil
Novartis Investigative Site, Victoria, British Columbia, Canada
Novartis Investigative Site, Halifax, Nova Scotia, Canada
Novartis Investigative Site, Oakville, Ontario, Canada
Novartis Investigative Site, Ottawa, Ontario, Canada
Novartis Investigative Site, Toronto, Ontario, Canada
Novartis Investigative Site, Montreal, Quebec, Canada
Novartis Investigative Site, Montreal, Quebec, Canada
Novartis Investigative Site, Montreal, Quebec, Canada
Novartis Investigative Site, Québec, Quebec, Canada
Novartis Investigative Site, Saskatoon, Saskatchewan, Canada
Novartis Investigative Site, Beijing, Beijing Municipality, China
Novartis Investigative Site, Guangzhou, Guangdong, China
Novartis Investigative Site, Harbin, Heilongjiang, China
Novartis Investigative Site, Zhengzhou, Henan, China
Novartis Investigative Site, Zhengzhou, Henan, China
Novartis Investigative Site, Nanjing, Jiangsu, China
Novartis Investigative Site, Nanchang, Jiangxi, China
Novartis Investigative Site, Changchun, Jilin, China
Novartis Investigative Site, Jinan, Shandong, China
Novartis Investigative Site, Jinan, Shandong, China
Novartis Investigative Site, Jining, Shandong, China
Novartis Investigative Site, Chengdu, Sichuan, China
Novartis Investigative Site, Chengdu, Sichuan, China
Novartis Investigative Site, Ürümqi, Xinjiang, China
Novartis Investigative Site, Hangzhou, Zhejiang, China
Novartis Investigative Site, Hangzhou, Zhejiang, China
Novartis Investigative Site, Wenzhou, Zhejiang, China
Novartis Investigative Site, Beijing, China
Novartis Investigative Site, Beijing, China
Novartis Investigative Site, Guangzhou, China
Novartis Investigative Site, Qingdao, China
Novartis Investigative Site, Shanghai, China
Novartis Investigative Site, Shijiazhuang, China
Novartis Investigative Site, Tianjin, China
Novartis Investigative Site, Freiburg im Breisgau, Baden-Wurttemberg, Germany
Novartis Investigative Site, Munich, Bavaria, Germany
Novartis Investigative Site, Regensburg, Bavaria, Germany
Novartis Investigative Site, Weiden in Der Oberpfalz, Bavaria, Germany
Novartis Investigative Site, Langen, Hesse, Germany
Novartis Investigative Site, Hildesheim, Lower Saxony, Germany
Novartis Investigative Site, Bergisch Gladbach, North Rhine-Westphalia, Germany
Novartis Investigative Site, Bielefeld, North Rhine-Westphalia, Germany
Novartis Investigative Site, Düsseldorf, North Rhine-Westphalia, Germany
Novartis Investigative Site, Essen, North Rhine-Westphalia, Germany
Novartis Investigative Site, Mönchengladbach, North Rhine-Westphalia, Germany
Novartis Investigative Site, Velbert, North Rhine-Westphalia, Germany
Novartis Investigative Site, Dresden, Saxony, Germany
Novartis Investigative Site, Lübeck, Schleswig-Holstein, Germany
Novartis Investigative Site, Augsburg, Germany
Novartis Investigative Site, Augsburg, Germany
Novartis Investigative Site, Berlin, Germany
Novartis Investigative Site, Berlin, Germany
Novartis Investigative Site, Bottrop, Germany
Novartis Investigative Site, Böblingen, Germany
Novartis Investigative Site, Dessau, Germany
Novartis Investigative Site, Erlangen, Germany
Novartis Investigative Site, Essen, Germany
Novartis Investigative Site, Hamburg, Germany
Novartis Investigative Site, Kiel, Germany
Novartis Investigative Site, Leipzig, Germany
Novartis Investigative Site, Mainz, Germany
Novartis Investigative Site, München, Germany
Novartis Investigative Site, Ravensburg, Germany
Novartis Investigative Site, Hong Kong, Hong Kong
Novartis Investigative Site, Kowloon, Hong Kong
Novartis Investigative Site, Tuenmen, Hong Kong
Novartis Investigative Site, Hyderabad, Andhra Pradesh, India
Novartis Investigative Site, Bangalore, Karnataka, India
Novartis Investigative Site, Mumbai, Maharashtra, India
Novartis Investigative Site, Pune, Maharasthra, India
Novartis Investigative Site, New Delhi, National Capital Territory of Delhi, India
Novartis Investigative Site, Bhubaneswar, Odisha, India
Novartis Investigative Site, Chennai, Tamil Nadu, India
Novartis Investigative Site, Kolkata, West Bengal, India
Novartis Investigative Site, Ahmedabad, India
Novartis Investigative Site, Beersheba, Israel
Novartis Investigative Site, Petah Tikva, Israel
Novartis Investigative Site, Ramat Gan, Israel
Novartis Investigative Site, Tel Aviv, Israel
Novartis Investigative Site, Alc Cuahutemoc, Mexico City, Mexico
Novartis Investigative Site, Tlalpan, Mexico City, Mexico
Novartis Investigative Site, Monterrey, Nuevo León, Mexico
Novartis Investigative Site, Coimbra, Portugal
Novartis Investigative Site, Lisbon, Portugal
Novartis Investigative Site, Lisbon, Portugal
Novartis Investigative Site, Porto, Portugal
Novartis Investigative Site, Porto, Portugal
Novartis Investigative Site, Porto, Portugal
Pan Oncology, Rio Piedras, Puerto Rico
Contact: Study coordinator (Nathalia Verge) · nathalia.verge@panoncologytrials.com · +1 787 407 3333
Contact: Principal Investigator (Omayra Gonzalez Rodriguez)
Novartis Investigative Site, Bundang Gu, Gyeonggi-do, South Korea
Novartis Investigative Site, Gyeonggi-do, Korea, South Korea
Novartis Investigative Site, Incheon, Korea, South Korea
Novartis Investigative Site, Seoul, Korea, South Korea
Novartis Investigative Site, Seoul, Yangcheon Gu, South Korea
Novartis Investigative Site, Seongnam Gyeonggi, South Korea
Novartis Investigative Site, Seoul, South Korea
Novartis Investigative Site, Seoul, South Korea
Novartis Investigative Site, Seoul, South Korea
Novartis Investigative Site, Seoul, South Korea
Novartis Investigative Site, Seoul, South Korea
Novartis Investigative Site, Seoul, South Korea
Novartis Investigative Site, Hualien City, Taiwan
Novartis Investigative Site, Kaohsiung City, Taiwan
Novartis Investigative Site, Tainan, Taiwan
Novartis Investigative Site, Taipei, Taiwan
Novartis Investigative Site, Taipei, Taiwan
Novartis Investigative Site, Sakarya, Adapazari, Turkey (Türkiye)
Novartis Investigative Site, Ankara, Bilkent-Cankaya, Turkey (Türkiye)
Novartis Investigative Site, Istanbul, Fatih, Turkey (Türkiye)
Novartis Investigative Site, Istanbul, Kadikoy, Turkey (Türkiye)
Novartis Investigative Site, Izmir, Karsiyaka, Turkey (Türkiye)
Novartis Investigative Site, Denizli, Kinikli, Turkey (Türkiye)
Novartis Investigative Site, Antalya, Konyaalti, Turkey (Türkiye)
Novartis Investigative Site, Istanbul, Sariyer, Turkey (Türkiye)
Novartis Investigative Site, Ankara, Sihhiye-Altindag, Turkey (Türkiye)
Novartis Investigative Site, Diyarbakır, Sur, Turkey (Türkiye)
Novartis Investigative Site, Istanbul, Uskudar, Turkey (Türkiye)
Novartis Investigative Site, Ankara, Yenimahalle, Turkey (Türkiye)
Novartis Investigative Site, Ankara, Yenimahalle, Turkey (Türkiye)
Novartis Investigative Site, Adana, Yuregir, Turkey (Türkiye)
Novartis Investigative Site, Ankara, Turkey (Türkiye)
Novartis Investigative Site, Istanbul, Turkey (Türkiye)
Novartis Investigative Site, Izmir, Turkey (Türkiye)
Novartis Investigative Site, Kecioren Ankara, Turkey (Türkiye)
Novartis Investigative Site, Konya, Turkey (Türkiye)
Novartis Investigative Site, Samsun, Turkey (Türkiye)

מובילי המחקר

Novartis Pharmaceuticals
Study Director
Novartis Pharmaceuticals

צפייה במקור ב־ClinicalTrials.gov פנייה לחוקר (אימייל)